Core Laboratories (NYSE:CLB) Sets New 1-Year High – What’s Next?

Shares of Core Laboratories Inc. (NYSE:CLB) hit a new 52-week high during trading on Friday . The company traded as high as $20.36 and last traded at $20.0010, with a volume of 12153 shares changing hands. The stock had previously closed at $19.63.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Core Laboratories in a research report on Monday, December 29th. Four investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Core Laboratories has a consensus rating of “Hold” and a consensus price target of $12.50.

Core Laboratories Price Performance

The company has a quick ratio of 1.76, a current ratio of 2.37 and a debt-to-equity ratio of 0.41. The stock has a market capitalization of $905.50 million, a P/E ratio of 29.03, a P/E/G ratio of 16.98 and a beta of 1.03. The firm has a fifty day moving average price of $16.88 and a two-hundred day moving average price of $14.00.

Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, October 22nd. The oil and gas company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.03. The firm had revenue of $134.52 million during the quarter, compared to analyst estimates of $130.92 million. Core Laboratories had a net margin of 6.21% and a return on equity of 12.85%. The business’s revenue was up .1% on a year-over-year basis. During the same quarter last year, the business earned $0.25 EPS. On average, analysts expect that Core Laboratories Inc. will post 0.96 EPS for the current year.

Institutional Investors Weigh In On Core Laboratories

A number of institutional investors and hedge funds have recently modified their holdings of CLB. Farther Finance Advisors LLC boosted its holdings in Core Laboratories by 154.2% during the 4th quarter. Farther Finance Advisors LLC now owns 9,945 shares of the oil and gas company’s stock valued at $159,000 after acquiring an additional 6,033 shares during the period. SG Americas Securities LLC purchased a new stake in shares of Core Laboratories during the fourth quarter valued at $265,000. CWA Asset Management Group LLC bought a new position in shares of Core Laboratories in the fourth quarter worth about $9,978,000. GAMMA Investing LLC increased its stake in Core Laboratories by 73.3% in the 4th quarter. GAMMA Investing LLC now owns 5,157 shares of the oil and gas company’s stock worth $83,000 after buying an additional 2,181 shares during the period. Finally, PharVision Advisers LLC bought a new stake in Core Laboratories during the 3rd quarter valued at about $218,000. 97.81% of the stock is owned by institutional investors.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.